Psychiatry AtlasMedication guide · United States

Stimulant medicine for ADHD

Dexmethylphenidate (Focalin, Focalin XR)

Generic name
dexmethylphenidate hydrochloride
Brand names
Focalin; Focalin XR
Medication class
Stimulant medicine for ADHD
Forms covered
Focalin immediate-release tablets; Focalin XR extended-release capsules

Article updated: 2026-10-30 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

FDA Boxed Warning

Focalin immediate-release tablets; Focalin XR extended-release capsules.

Focalin and Focalin XR have a high potential for abuse, misuse and addiction. Misuse can cause overdose or death, especially at higher doses or through unapproved routes. Assess risk before treatment, monitor throughout, and use secure storage and safe disposal.

Dexmethylphenidate treats ADHD. Focalin immediate-release tablets and Focalin XR capsules have different schedules and maximum doses; the medicine is not milligram-equivalent to racemic methylphenidate.

What to expect: Effects on attention and impulse control can be noticeable on a day a dose is taken.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • ADHD — Adults and children age 6 or older. Product-specific age evidence, schedule and maximum dose.Focalin immediate-release tablets; Focalin XR extended-release capsules.

What should I expect?

Effects on attention and impulse control can be noticeable on a day a dose is taken. The useful duration varies with the immediate- or extended-release product and the individual.

Finding a workable regimen still requires follow-up. Track functioning, appetite, sleep and when benefit wears off; feeling more stimulated is not the treatment goal.

How do I take it safely?

Immediate-release Focalin is usually taken twice daily at least four hours apart; Focalin XR is taken in the morning. Food is optional. XR capsules may be opened onto applesauce: take all contents immediately without chewing; do not divide the beads.

Before and during treatment, assess heart and family history, blood pressure, pulse, appetite, sleep, mood and tics. Children need height and weight checks. Covered products treat ADHD from age 6; the current XR label advises against use below 6.

Do not combine with an MAOI or use within 14 days after stopping one. Review other medicines, heart disease, eye problems, pregnancy and breastfeeding with the clinician. Keep the medicine locked away, never share it and use a pharmacy disposal option for unused doses.

Never double a forgotten dose or take a late catch-up dose without advice. Plan dose reductions with the prescriber: abrupt stopping after prolonged use can cause fatigue, low mood and sleep changes.

Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.

What side effects should I know about?

  • Reduced appetite, insomnia, abdominal discomfort, headache or nervousness.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • The boxed warning covers abuse, misuse and addiction; misuse can cause overdose or death.
  • Seek emergency assessment for chest pain, fainting, a seizure, severe agitation or suspected overdose. A prolonged painful erection or sudden eye pain or vision change requires immediate assessment. Severe allergy or breathing difficulty is an emergency.
  • Report new hallucinations, mania, worsening tics or painful, cold or discolored fingers or toes promptly. Heart disease, growth suppression and increases in blood pressure or pulse need ongoing attention.
  • Focalin XR is not approved or recommended for ADHD below age 6. Younger children have higher drug exposure and more side effects, including weight loss, with extended-release stimulants. Report weight loss or slowed growth to the prescriber; any change needs a clinician’s plan. Immediate-release age instructions do not apply to this form.

What else should I know to stay safe?

  • Do not use with an MAOI or within 14 days after stopping one, or after product allergy. Serious heart disease, eye problems, bipolar or psychotic symptoms and tics need assessment before treatment.
  • Monitor blood pressure, pulse, sleep, appetite and mood; children need height and weight monitoring. Discuss pregnancy and breastfeeding. Keep the medicine secure, never share it and use an appropriate disposal route.
  • Plan reductions after regular use with the prescriber: abrupt stopping can cause pronounced fatigue, low mood and sleep changes.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Useful benefit is better day-to-day functioning, rather than a noticeable rush or a stronger stimulant sensation.
  • Extended release changes how long medicine is delivered. It does not remove the need to monitor appetite, sleep, growth, pulse and blood pressure.

How does it work?

Dexmethylphenidate changes the availability of dopamine and norepinephrine, chemical messengers used by nerve cells. It is the more active of the two mirror-image molecular forms found in methylphenidate. Its effects on these messengers are known, while the full explanation of how it improves attention-deficit/hyperactivity disorder (ADHD) symptoms remains uncertain.

Explore medication science

How was this medicine developed?

Focalin tablets were approved in 2001 and Focalin XR capsules in 2005. Dexmethylphenidate contains one of the two mirror-image forms found in methylphenidate, so the medicines are not milligram-for-milligram equivalents.

How do I say the name?

Dexmethylphenidate: dex-meth-il-FEN-i-date. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Focalin (dexmethylphenidate) tablets: prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: 12.1 Mechanism of Action; 12.2 Pharmacodynamics; 12.3 Pharmacokinetics..

  2. Dexmethylphenidate: FDA approval history
  3. Dexmethylphenidate: patient medicine information

    Scope: United States; general safety education only.

  4. Focalin XR (dexmethylphenidate): prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: 11 Description; 12.1 Mechanism of Action; 12.2 Pharmacodynamics; 12.3 Pharmacokinetics..

  5. Focalin XR FDA approval history
  6. FDA requires expanded labeling about weight loss risk in patients younger than 6 years taking extended-release stimulants for ADHD
  7. Focalin XR FDA prescribing information
  8. Focalin XR: Package Insert / Prescribing Information / MOA
  9. Methylphenidate: prescribing information
  10. Dexmethylphenidate: verified neutral parent, PubChem CID 154101
  11. ISMP List of Confused Drug Names
  12. Focalin tablets — FDA prescribing information
  13. Frequently Asked Questions about Labeling for Prescription Medicines | FDA
  14. Schizophrenia
  15. NIMH: Understanding psychosis

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top